Related Experiment Videos
Persistent chest opacity in trophoblastic disease: is thoracotomy justified?
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|November 1, 1983
Summary
Gestational trophoblastic tumors with lung metastases require chemotherapy. Close follow-up with human chorionic gonadotropin (HCG) assays is crucial for detecting relapse in these high-risk patients.
Area of Science:
- Gynecology
- Oncology
- Pulmonary Medicine
Background:
- Gestational trophoblastic tumors (GTT) are rare placental malignancies.
- Persistent GTT requires effective treatment strategies, especially when pulmonary metastases are present.
Observation:
- From 1972-1980, 138 patients with persistent GTT were treated at the University Gynaecological Unit.
- Forty patients had pulmonary metastases, treated with chemotherapy; 5 died early.
- 35 patients achieved biochemical remission, but 5 had persistent chest shadows and 2 showed active disease.
Findings:
- Chemotherapy was the primary treatment for pulmonary metastases.
- Thoracotomy's therapeutic and prognostic value in GTT is uncertain.
- Patients achieving remission remain at increased risk for relapse.
Implications:
- Long-term monitoring using human chorionic gonadotropin (HCG) assays is essential for early relapse detection.
- Risk stratification and vigilant follow-up are critical for managing GTT survivors.
- Further research into optimal management of persistent GTT with pulmonary involvement is warranted.